Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications
Antonietta M Lillo,1 Nileena Velappan,1 Julia M Kelliher,1 Austin J Watts,1 Samuel P Merriman,1 Grace Vuyisich,2 Laura M Lilley,2 Kent E Coombs,1 Tara Mastren,2 Munehiro Teshima,1 Benjamin W Stein,2 Gregory L Wagner,2 Srinivas Iyer,1 Andrew RM Bradbury,3 Jennifer Foster Harris,1 Armand E Dichosa,1 S...
Main Authors: | Lillo AM, Velappan N, Kelliher JM, Watts AJ, Merriman SP, Vuyisich G, Lilley LM, Coombs KE, Mastren T, Teshima M, Stein BW, Wagner GL, Iyer S, Bradbury ARM, Harris JF, Dichosa AE, Kozimor SA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/development-of-anti-yersinia-pestis-human-antibodies-with-features-req-peer-reviewed-article-ITT |
Similar Items
-
Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy
by: Wiebke Sihver, et al.
Published: (2014-03-01) -
Radiolabeled Antibodies for Cancer Imaging and Therapy
by: Sagun Parakh, et al.
Published: (2022-03-01) -
Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose–Volume–Effect Correlation
by: Kim Melanie Kraus, et al.
Published: (2022-06-01) -
Potential for Nuclear Medicine Therapy for Glioblastoma Treatment
by: Clément Bailly, et al.
Published: (2019-07-01) -
The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines
by: Gro Elise Rødland, et al.
Published: (2019-11-01)